My understanding is that another phase 3 trial is required before it will go up for FDA Approval.
Same goes with the CLBP trial... that is why they partnered up for a European trial.
If the current phase 3 CHF trial is successful, next step should be a US partner to fund and run the pivotal phase 3 trial.
Unless the goal posts have changed?
My understanding is that another phase 3 trial is required...
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.050(3.58%) |
Mkt cap ! $1.621B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.45 | $1.40 | $2.594M | 1.823M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 21493 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 442572 | 26 |
View Market Depth
| Last trade - 12.08pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |